$2.63B
$8.29 Million
0.0% of portfolio
109,845
Q3 2024
Added 65.76%
$14.1B
$7.39 Million
0.0% of portfolio
94,321
Q3 2024
Reduced 24.2%
$185M
$417,000
0.0% of portfolio
111,507
Q3 2024
Added 195.31%
$2.08B
$2.78 Million
0.0% of portfolio
206,967
Q3 2024
Added 305.28%
-
$161,000
0.0% of portfolio
-
Q3 2024
Reduced 28.86%
$134M
$256,000
0.0% of portfolio
20,806
Q3 2024
Added 388.17%
$4.29B
$8.72 Million
0.0% of portfolio
640,844
Q3 2024
Reduced 18.88%
$54.1M
$5,000
0.0% of portfolio
1,251
Q1 2024
New
$717M
$694,000
0.0% of portfolio
74,119
Q3 2024
Added 63.35%
$3.34B
$3.16 Million
0.0% of portfolio
120,502
Q3 2024
Added 44.77%
$250M
$352,000
0.0% of portfolio
65,468
Q3 2024
Added 45.41%
Perspective Therapeutics Inc
-
$1.52 Million
0.0% of portfolio
-
Q3 2024
Added 587.94%
$768M
$985,000
0.0% of portfolio
216,564
Q3 2024
Reduced 54.09%
$908M
$1.32 Million
0.0% of portfolio
42,805
Q3 2024
Reduced 55.31%
-
$11.7 Million
0.0% of portfolio
890,000
Q3 2024
Added 15.58%
$90.6B
$4.51 Million
0.0% of portfolio
313,307
Q3 2024
Reduced 41.19%
$608M
$106,000
0.0% of portfolio
5,700
Q3 2024
New
$245M
$1.04 Million
0.0% of portfolio
57,807
Q3 2024
Added 366.0%
$447M
$3.23 Million
0.0% of portfolio
143,337
Q3 2024
Added 25.66%
$4.31B
$10.5 Million
0.0% of portfolio
279,432
Q3 2024
Added 49.19%
-
$3.35 Million
0.0% of portfolio
-
Q3 2024
Added 336.19%
$1.39B
$2.83 Million
0.0% of portfolio
114,133
Q3 2024
Added 297.18%
$1.54B
$2.16 Million
0.0% of portfolio
94,929
Q3 2024
Added 83.6%
-
$1,000
0.0% of portfolio
-
Q3 2024
Reduced 69.53%
$144M
$37,000
0.0% of portfolio
10,960
Q3 2024
New
$158M
$307,000
0.0% of portfolio
34,322
Q3 2024
Added 104.87%
$879M
$2.4 Million
0.0% of portfolio
237,407
Q3 2024
Added 88.7%
Pieris Pharmaceuticals Inc
-
$1,000
0.0% of portfolio
-
Q2 2024
New
$11.1B
$3.52 Million
0.0% of portfolio
76,364
Q3 2024
Added 345.63%
$0
$239,000
0.0% of portfolio
2,900
Q3 2024
Reduced 25.64%
$0
$1.76 Million
0.0% of portfolio
18,400
Q3 2024
Reduced 48.75%
$9.51B
$16.4 Million
0.0% of portfolio
167,838
Q3 2024
Added 116.96%
$9.71B
$18 Million
0.0% of portfolio
203,363
Q3 2024
Added 7.62%
$301M
$206,000
0.0% of portfolio
18,757
Q3 2024
Added 369.98%
$4.26B
$9.17 Million
0.0% of portfolio
32,328
Q3 2024
Added 307.15%
$1.54B
$1.98 Million
0.0% of portfolio
277,469
Q3 2024
Added 298.48%
$46.2M
$291,000
0.0% of portfolio
410,157
Q2 2024
Reduced 30.28%
$4B
$6.94 Million
0.0% of portfolio
52,045
Q3 2024
Added 158.63%
$4.22B
$15.3 Million
0.0% of portfolio
825,497
Q3 2024
Reduced 5.19%
$9.06B
$5.53 Million
0.0% of portfolio
68,009
Q3 2024
Reduced 80.2%
$1.36B
$728,000
0.0% of portfolio
326,147
Q3 2024
Added 24.98%
$123M
$4,000
0.0% of portfolio
2,900
Q4 2021
Reduced 43.14%
$2.06B
$165,000
0.0% of portfolio
21,240
Q3 2024
Added 993.72%
$447M
$6.24 Million
0.0% of portfolio
548,073
Q3 2024
Added 161.7%
$213M
$354,000
0.0% of portfolio
234,332
Q3 2024
Added 55.94%
$2.65B
$1.29 Million
0.0% of portfolio
163,138
Q3 2024
Added 4.81%
$4.87B
$1,000
0.0% of portfolio
54
Q1 2023
Reduced 14.29%
$3.97B
$6.67 Million
0.0% of portfolio
48,786
Q3 2024
Added 139.38%
$531M
$4.73 Million
0.0% of portfolio
421,499
Q3 2024
Added 22.91%
$1.09B
$7.23 Million
0.0% of portfolio
3,198,845
Q3 2024
Added 52.7%